Clinical Trial Update: Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) [NA]

View source ↗

Summary

This ClinicalTrials.gov entry outlines a study on consolidative metastasis and primary directed therapy (MPDT) for renal cell carcinoma, which is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Renal Cell Carcinoma | NA | Status: NOT_YET_RECRUITING